Clinical inquiries. What are effective treatments for oppositional defiant behaviors in adolescents?
Kelsberg
Gary
G
University of Washington Family Medicine Residency, Valley Medical Center, Renton, WA, USA.
St Anna
Leilani
L
Rulon
Elizabeth A
EA
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000188:drug therapy*; D015897:Comorbidity; D005194:Family Practice; D006801:Humans; D011437:Propylamines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D018692:Antimanic Agents; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride; D014635:Valproic Acid